# Pliant Therapeutics, Inc.: Form 8-K, filed Sep 27, 2024

- Company: [Pliant Therapeutics, Inc.](/companies/plrx.md) (CIK 1746473)
- Form: 8-K
- Filed: 2024-09-27
- Accepted by EDGAR: Sep 27, 2024, 20:11 ET
- Period: 2024-09-24
- Accession: 0001746473-24-000153
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1746473/000174647324000153/plrx-20240924.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1746473/000174647324000153/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1746473/000174647324000153/plrx-20240924.htm

Filed Sep 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001746473-24-000153. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.